logo
February 7 - 10, 2019 | Orlando

John Vandermosten

speaker photo BIOTECH

Senior Biotechnology Research Analyst

Zacks Investment Research

John Vandermosten is currently a senior biotechnology research analyst for Zacks Investment Research where he covers a portfolio of small-cap biotechnology names. His background includes 17 years of experience in a variety of investment management and research roles across all market cap ranges and throughout the capital structure. Formerly, Mr. Vandermosten was a research analyst for Singular Research covering the healthcare space and a consultant with Coker Group, a national healthcare services firm providing financial advisory, investment banking, healthcare IT, and other services to hospitals and other health care organizations.

Speaker Schedule

Drug Development: Threading Our Way Through the Labyrinth
February 9, 2019, 2:00 pm - 2:45 pm

Focus: HEALTHCARE